Articles

Results 1 to 5 of 29


Life sciences collaborations: Managing risk and resolving disputes throughout the life cycle

USA - November 29 2022 Life sciences collaborations often involve long-term complex commitments. For business development professionals and in-house lawyers, mitigating…

Milan Thakker, Matthew Townsend, May Ling Wong, Amy Yin

Confidentiality: Crucial and misunderstood

USA - November 9 2022 Confidentiality is a critical international arbitration benefit, but most stakeholders fail to appreciate the affirmative steps they need to take to…

Cost shifting in international arbitration promotes efficiency and full recovery

United Kingdom, USA - September 29 2022 The American Rule on costs - namely, that each side pays their own way in a litigation - is an egalitarian rule, but it doesn't often work well in…

Resolving life sciences disputes: Prescription or over-the-counter medicine?

Global - July 21 2022 As an in-house counsel working in the bio-pharma sector for 20 years, Ramzi has witnessed first-hand many of the advantages that arbitration can…

Gautam Bhattacharyya, Simon Greer, Casey J. Olbrantz, Peter Rosher

Section 1782 no longer a discovery tool in aid of private international arbitrations; ICSID in play?

USA - June 28 2022 On June 13, 2022, the U.S. Supreme Court unanimously held in the consolidated cases of ZF Automotive US, Inc., et al. v. Luxshare, Ltd., No. 21-401…

Anabel Blanco, Steven Cooper, Rebeca E. Mosquera, Ed Mullins, William W. Russell